Y. Fukuma

发表

Genetic backgrounds and redox conditions influence morphological characteristics and cell differentiation of osteoclasts in mice

E. Sakai, T. Tsukuba, Shun Narahara, 2012, Cell and Tissue Research.

Effects of deficiency of Kelch‐like ECH‐associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis

K. Itoh, Masayuki Yamamoto, M. Kido, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways

E. Sakai, T. Tsukuba, M. Iwatake, 2015, BioMetals.

Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.

Takashi Tanaka, E. Sakai, T. Tsukuba, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ‐B ligand‐stimulated signalling pathways

E. Sakai, T. Tsukuba, K. Okamoto, 2018, Clinical and experimental pharmacology & physiology.

Rutaecarpine attenuates osteoclastogenesis by impairing M-CSF and RANKL-stimulated signaling pathways

E. Sakai, T. Tsukuba, Y. Fukuma, 2018 .

Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation

E. Sakai, T. Tsukuba, M. Iwatake, 2015, Phytotherapy research : PTR.

Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation.

E. Sakai, T. Tsukuba, K. Okamoto, 2015, BioFactors.

Inhibitory effects of tert‐butylhydroquinone on osteoclast differentiation via up‐regulation of heme oxygenase‐1 and down‐regulation of HMGB1 release and NFATc1 expression

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2014, Journal of applied toxicology : JAT.

Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2013, Journal of pharmacological sciences.

Deltamethrin inhibits osteoclast differentiation via regulation of heme oxygenase-1 and NFATc1.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2012, Toxicology in vitro : an international journal published in association with BIBRA.

The coffee diterpene kahweol prevents osteoclastogenesis via impairment of NFATc1 expression and blocking of Erk phosphorylation.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2012, Journal of pharmacological sciences.